Company Bioxyne Limited

Equities

BXN

AU000000BXN6

Biotechnology & Medical Research

Delayed Australian S.E. 08:00:03 2024-04-25 pm EDT 5-day change 1st Jan Change
0.008 AUD +14.29% Intraday chart for Bioxyne Limited -11.11% -27.27%

Business Summary

Bioxyne Limited is an Australia-based health and wellness products company. Its activity is the development, manufacture and distribution of nutritional health and wellness supplements through indirect wholesale and direct sales channels in the health and wellness sector. It is engaged in the consumer dietary supplements and functional foods markets through its probiotic, Lactobacillus fermentum VRI-003 (PCC). The Company has developed a range of functional food and beauty products containing ingredients sourced primarily from New Zealand, through its direct sales business trading as Bioxyne International. It has an interest in Breathe Life Sciences (BLS). It has operations across Australia, the United Kingdom, Japan, Europe and Southeast Asia with a health and wellness product portfolio, including health supplements, skincare, probiotics, cannabis-derived raw materials, starting materials, active pharmaceutical ingredients, cannabinoid-based therapies and telemedicine technology.

Sales per Business

AUD in Million2022Weight2023Weight Delta
Plant Based
99.1 %
- - 5 99.1 % -
Wholesale
0.8 %
2 93.0 % 0 0.8 % -98.11%
Direct
0.1 %
0 7.0 % 0 0.1 % -98.43%

Sales per region

AUD in Million2022Weight2023Weight Delta
United Kingdom/Europe/Japan
99.1 %
-- 5 99.1 % -
United States
0.8 %
2 80.1 % 0 0.8 % -97.80%
Asia
0.1 %
0 19.9 % 0 0.1 % -99.45%

Managers

Managers TitleAgeSince
Chief Executive Officer - 23-05-18
Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Chairman 65 12-10-29
Director/Board Member - 23-05-18
Chief Executive Officer - 23-05-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,901,645,398 273,517,125 ( 14.38 %) 0 14.38 %

Shareholders

NameEquities%Valuation
Paramount Star Investments Ltd. (Singapore)
1.893 %
36,000,000 1.893 % 281 880 $

Company contact information

Bioxyne Ltd.

50 Clarence Street Suite 506, Level 5

2000, Sydney

+

http://www.bioxyne.com
address Bioxyne Limited(BXN)
  1. Stock Market
  2. Equities
  3. BXN Stock
  4. Company Bioxyne Limited